#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=The amide bonds existing in a large number of structures and forming the backbone of the biologically essential proteins are the most basic building blocks of chemistry in nature .
3-1	17-20	The	abstract[4]	new[4]	coref	3-21[9_4]
3-2	21-26	amide	substance|abstract[4]	new|new[4]	coref	4-1[12_0]
3-3	27-32	bonds	abstract[4]	new[4]	_	_
3-4	33-41	existing	_	_	_	_
3-5	42-44	in	_	_	_	_
3-6	45-46	a	abstract[5]	new[5]	_	_
3-7	47-52	large	abstract[5]	new[5]	_	_
3-8	53-59	number	abstract[5]	new[5]	_	_
3-9	60-62	of	abstract[5]	new[5]	_	_
3-10	63-73	structures	abstract[5]|abstract	new[5]|new	coref	16-1[136_0]
3-11	74-77	and	_	_	_	_
3-12	78-85	forming	_	_	_	_
3-13	86-89	the	abstract[7]	new[7]	_	_
3-14	90-98	backbone	abstract[7]	new[7]	_	_
3-15	99-101	of	abstract[7]	new[7]	_	_
3-16	102-105	the	abstract[7]|substance[8]	new[7]|new[8]	coref	4-17[0_8]
3-17	106-118	biologically	abstract[7]|substance[8]	new[7]|new[8]	_	_
3-18	119-128	essential	abstract[7]|substance[8]	new[7]|new[8]	_	_
3-19	129-137	proteins	abstract[7]|substance[8]	new[7]|new[8]	_	_
3-20	138-141	are	_	_	_	_
3-21	142-145	the	abstract[9]	giv[9]	coref	4-11[16_9]
3-22	146-150	most	abstract[9]	giv[9]	_	_
3-23	151-156	basic	abstract[9]	giv[9]	_	_
3-24	157-165	building	abstract[9]	giv[9]	_	_
3-25	166-172	blocks	abstract[9]	giv[9]	_	_
3-26	173-175	of	abstract[9]	giv[9]	_	_
3-27	176-185	chemistry	abstract[9]|abstract[10]	giv[9]|new[10]	_	_
3-28	186-188	in	abstract[9]|abstract[10]	giv[9]|new[10]	_	_
3-29	189-195	nature	abstract[9]|abstract[10]|abstract	giv[9]|new[10]|new	_	_
3-30	196-197	.	_	_	_	_

#Text=The amide is also essential due to its role in the peptide bonds in pharmaceuticals , proteins , and natural products .
4-1	198-201	The	substance[12]	giv[12]	ana	4-8[0_12]
4-2	202-207	amide	substance[12]	giv[12]	_	_
4-3	208-210	is	_	_	_	_
4-4	211-215	also	_	_	_	_
4-5	216-225	essential	_	_	_	_
4-6	226-229	due	_	_	_	_
4-7	230-232	to	_	_	_	_
4-8	233-236	its	substance|abstract[14]	giv|new[14]	coref|coref|coref|coref	5-1|7-15[49_14]|5-1|7-15[49_14]
4-9	237-241	role	abstract[14]	new[14]	_	_
4-10	242-244	in	abstract[14]	new[14]	_	_
4-11	245-248	the	abstract[14]|abstract[16]	new[14]|giv[16]	coref	5-1[21_16]
4-12	249-256	peptide	abstract[14]|object|abstract[16]	new[14]|new|giv[16]	_	_
4-13	257-262	bonds	abstract[14]|abstract[16]	new[14]|giv[16]	_	_
4-14	263-265	in	abstract[14]|abstract[16]	new[14]|giv[16]	_	_
4-15	266-281	pharmaceuticals	abstract[14]|abstract[16]|substance	new[14]|giv[16]|new	_	_
4-16	282-283	,	abstract[14]|abstract[16]	new[14]|giv[16]	_	_
4-17	284-292	proteins	abstract[14]|abstract[16]|substance	new[14]|giv[16]|giv	_	_
4-18	293-294	,	abstract[14]|abstract[16]	new[14]|giv[16]	_	_
4-19	295-298	and	abstract[14]|abstract[16]	new[14]|giv[16]	_	_
4-20	299-306	natural	abstract[14]|abstract[16]|substance[19]	new[14]|giv[16]|new[19]	_	_
4-21	307-315	products	abstract[14]|abstract[16]|substance[19]	new[14]|giv[16]|new[19]	_	_
4-22	316-317	.	_	_	_	_

#Text=Amide bonds are characteristically synthesized by combining carboxylic acids and amines ; however , the association of these two functional groups does not occur at room temperature .
5-1	318-323	Amide	substance|abstract[21]	giv|giv[21]	_	_
5-2	324-329	bonds	abstract[21]	giv[21]	_	_
5-3	330-333	are	_	_	_	_
5-4	334-352	characteristically	_	_	_	_
5-5	353-364	synthesized	_	_	_	_
5-6	365-367	by	_	_	_	_
5-7	368-377	combining	_	_	_	_
5-8	378-388	carboxylic	person|substance[23]	new|new[23]	_	_
5-9	389-394	acids	substance[23]	new[23]	_	_
5-10	395-398	and	_	_	_	_
5-11	399-405	amines	substance	new	coref	6-43
5-12	406-407	;	_	_	_	_
5-13	408-415	however	_	_	_	_
5-14	416-417	,	_	_	_	_
5-15	418-421	the	event[25]	new[25]	_	_
5-16	422-433	association	event[25]	new[25]	_	_
5-17	434-436	of	event[25]	new[25]	_	_
5-18	437-442	these	event[25]|person[26]	new[25]|new[26]	_	_
5-19	443-446	two	event[25]|person[26]	new[25]|new[26]	_	_
5-20	447-457	functional	event[25]|person[26]	new[25]|new[26]	_	_
5-21	458-464	groups	event[25]|person[26]	new[25]|new[26]	_	_
5-22	465-469	does	_	_	_	_
5-23	470-473	not	_	_	_	_
5-24	474-479	occur	_	_	_	_
5-25	480-482	at	_	_	_	_
5-26	483-487	room	abstract[27]	new[27]	_	_
5-27	488-499	temperature	abstract[27]	new[27]	_	_
5-28	500-501	.	_	_	_	_

#Text=Over the past decades , many researchers have proposed alternative synthesis methods , such as the Staudinger reaction , direct amidation of aldehydes , transition-metal-catalyzed aminocarbonylation , and hydrating coupling of alkynes with azides , esters , alcohols , and alkynes with amines .
6-1	502-506	Over	_	_	_	_
6-2	507-510	the	time[28]	new[28]	_	_
6-3	511-515	past	time[28]	new[28]	_	_
6-4	516-523	decades	time[28]	new[28]	_	_
6-5	524-525	,	_	_	_	_
6-6	526-530	many	person[29]	new[29]	_	_
6-7	531-542	researchers	person[29]	new[29]	_	_
6-8	543-547	have	_	_	_	_
6-9	548-556	proposed	_	_	_	_
6-10	557-568	alternative	abstract[31]	new[31]	coref	8-6[0_31]
6-11	569-578	synthesis	abstract|abstract[31]	new|new[31]	coref	8-8[59_0]
6-12	579-586	methods	abstract[31]	new[31]	_	_
6-13	587-588	,	abstract[31]	new[31]	_	_
6-14	589-593	such	abstract[31]	new[31]	_	_
6-15	594-596	as	abstract[31]	new[31]	_	_
6-16	597-600	the	abstract[31]|event[33]	new[31]|new[33]	coref	9-25[72_33]
6-17	601-611	Staudinger	abstract[31]|person|event[33]	new[31]|new|new[33]	_	_
6-18	612-620	reaction	abstract[31]|event[33]	new[31]|new[33]	_	_
6-19	621-622	,	abstract[31]	new[31]	_	_
6-20	623-629	direct	abstract[31]|substance[34]	new[31]|new[34]	coref	9-28[0_34]
6-21	630-639	amidation	abstract[31]|substance[34]	new[31]|new[34]	_	_
6-22	640-642	of	abstract[31]|substance[34]	new[31]|new[34]	_	_
6-23	643-652	aldehydes	abstract[31]|substance[34]|substance	new[31]|new[34]|new	coref	9-31[73_0]
6-24	653-654	,	abstract[31]|substance[34]	new[31]|new[34]	_	_
6-25	655-681	transition-metal-catalyzed	abstract[31]|substance[34]|substance[36]	new[31]|new[34]|new[36]	_	_
6-26	682-700	aminocarbonylation	abstract[31]|substance[34]|substance[36]	new[31]|new[34]|new[36]	_	_
6-27	701-702	,	_	_	_	_
6-28	703-706	and	_	_	_	_
6-29	707-716	hydrating	abstract[37]	new[37]	_	_
6-30	717-725	coupling	abstract[37]	new[37]	_	_
6-31	726-728	of	abstract[37]	new[37]	_	_
6-32	729-736	alkynes	abstract[37]|substance[38]	new[37]|new[38]	_	_
6-33	737-741	with	abstract[37]|substance[38]	new[37]|new[38]	_	_
6-34	742-748	azides	abstract[37]|substance[38]|substance	new[37]|new[38]|new	_	_
6-35	749-750	,	abstract[37]|substance[38]	new[37]|new[38]	_	_
6-36	751-757	esters	abstract[37]|substance[38]|substance	new[37]|new[38]|new	_	_
6-37	758-759	,	abstract[37]|substance[38]	new[37]|new[38]	_	_
6-38	760-768	alcohols	abstract[37]|substance[38]|substance	new[37]|new[38]|new	_	_
6-39	769-770	,	abstract[37]|substance[38]	new[37]|new[38]	_	_
6-40	771-774	and	abstract[37]|substance[38]	new[37]|new[38]	_	_
6-41	775-782	alkynes	abstract[37]|substance[38]|substance[42]	new[37]|new[38]|new[42]	coref	9-17[68_42]
6-42	783-787	with	abstract[37]|substance[38]|substance[42]	new[37]|new[38]|new[42]	_	_
6-43	788-794	amines	abstract[37]|substance[38]|substance[42]|substance	new[37]|new[38]|new[42]|giv	coref	9-33
6-44	795-796	.	_	_	_	_

#Text=Pyridyl benzamides are one of the most critical types of N-heterocyclic amides and play an essential role in the composition of many important medicines ( e. g. , antiulcer agents , kinetoplastid inhibitors , antifungal agents , and luciferase inhibitors ) .
7-1	797-804	Pyridyl	abstract|substance[45]	new|new[45]	coref|coref|coref|coref	8-11|8-11[61_45]|8-11|8-11[61_45]
7-2	805-815	benzamides	substance[45]	new[45]	_	_
7-3	816-819	are	_	_	_	_
7-4	820-823	one	object[46]	new[46]	_	_
7-5	824-826	of	object[46]	new[46]	_	_
7-6	827-830	the	object[46]|place[47]	new[46]|new[47]	_	_
7-7	831-835	most	object[46]|place[47]	new[46]|new[47]	_	_
7-8	836-844	critical	object[46]|place[47]	new[46]|new[47]	_	_
7-9	845-850	types	object[46]|place[47]	new[46]|new[47]	_	_
7-10	851-853	of	object[46]|place[47]	new[46]|new[47]	_	_
7-11	854-868	N-heterocyclic	object[46]|place[47]|substance[48]	new[46]|new[47]|new[48]	coref	10-2[76_48]
7-12	869-875	amides	object[46]|place[47]|substance[48]	new[46]|new[47]|new[48]	_	_
7-13	876-879	and	_	_	_	_
7-14	880-884	play	_	_	_	_
7-15	885-887	an	abstract[49]	giv[49]	_	_
7-16	888-897	essential	abstract[49]	giv[49]	_	_
7-17	898-902	role	abstract[49]	giv[49]	_	_
7-18	903-905	in	abstract[49]	giv[49]	_	_
7-19	906-909	the	abstract[49]|abstract[50]	giv[49]|new[50]	_	_
7-20	910-921	composition	abstract[49]|abstract[50]	giv[49]|new[50]	_	_
7-21	922-924	of	abstract[49]|abstract[50]	giv[49]|new[50]	_	_
7-22	925-929	many	abstract[49]|abstract[50]|substance[51]	giv[49]|new[50]|new[51]	_	_
7-23	930-939	important	abstract[49]|abstract[50]|substance[51]	giv[49]|new[50]|new[51]	_	_
7-24	940-949	medicines	abstract[49]|abstract[50]|substance[51]	giv[49]|new[50]|new[51]	_	_
7-25	950-951	(	_	_	_	_
7-26	952-954	e.	_	_	_	_
7-27	955-957	g.	_	_	_	_
7-28	958-959	,	_	_	_	_
7-29	960-969	antiulcer	person[52]	new[52]	_	_
7-30	970-976	agents	person[52]	new[52]	_	_
7-31	977-978	,	_	_	_	_
7-32	979-992	kinetoplastid	object[53]	new[53]	_	_
7-33	993-1003	inhibitors	object[53]	new[53]	_	_
7-34	1004-1005	,	_	_	_	_
7-35	1006-1016	antifungal	person[54]	new[54]	coref	27-30[234_54]
7-36	1017-1023	agents	person[54]	new[54]	_	_
7-37	1024-1025	,	_	_	_	_
7-38	1026-1029	and	_	_	_	_
7-39	1030-1040	luciferase	object|object[56]	new|new[56]	_	_
7-40	1041-1051	inhibitors	object[56]	new[56]	_	_
7-41	1052-1053	)	_	_	_	_
7-42	1054-1055	.	_	_	_	_

#Text=Lately , the number of methods for the synthesis of pyridyl benzamides has been rising significantly .
8-1	1056-1062	Lately	_	_	_	_
8-2	1063-1064	,	_	_	_	_
8-3	1065-1068	the	abstract[57]	new[57]	_	_
8-4	1069-1075	number	abstract[57]	new[57]	_	_
8-5	1076-1078	of	abstract[57]	new[57]	_	_
8-6	1079-1086	methods	abstract[57]|abstract	new[57]|giv	_	_
8-7	1087-1090	for	abstract[57]	new[57]	_	_
8-8	1091-1094	the	abstract[57]|abstract[59]	new[57]|giv[59]	_	_
8-9	1095-1104	synthesis	abstract[57]|abstract[59]	new[57]|giv[59]	_	_
8-10	1105-1107	of	abstract[57]|abstract[59]	new[57]|giv[59]	_	_
8-11	1108-1115	pyridyl	abstract[57]|abstract[59]|abstract|substance[61]	new[57]|giv[59]|giv|giv[61]	coref|coref|coref|coref	10-20|10-20[81_61]|10-20|10-20[81_61]
8-12	1116-1126	benzamides	abstract[57]|abstract[59]|substance[61]	new[57]|giv[59]|giv[61]	_	_
8-13	1127-1130	has	_	_	_	_
8-14	1131-1135	been	_	_	_	_
8-15	1136-1142	rising	_	_	_	_
8-16	1143-1156	significantly	_	_	_	_
8-17	1157-1158	.	_	_	_	_

#Text=Typical examples include the Cu-catalyzed oxidation of methyl ketones , Cu-catalyzed oxidative coupling of 2-aminopyridines and terminal alkynes with visible light mediation , and the direct oxidative amidation reaction of aldehydes with amines .
9-1	1159-1166	Typical	abstract[62]	new[62]	_	_
9-2	1167-1175	examples	abstract[62]	new[62]	_	_
9-3	1176-1183	include	_	_	_	_
9-4	1184-1187	the	abstract[63]	new[63]	coref	18-22[0_63]
9-5	1188-1200	Cu-catalyzed	abstract[63]	new[63]	_	_
9-6	1201-1210	oxidation	abstract[63]	new[63]	_	_
9-7	1211-1213	of	abstract[63]	new[63]	_	_
9-8	1214-1220	methyl	abstract[63]|object[64]	new[63]|new[64]	_	_
9-9	1221-1228	ketones	abstract[63]|object[64]	new[63]|new[64]	_	_
9-10	1229-1230	,	abstract[63]	new[63]	_	_
9-11	1231-1243	Cu-catalyzed	abstract[63]|abstract[66]	new[63]|new[66]	coref	18-28[0_66]
9-12	1244-1253	oxidative	abstract[63]|person|abstract[66]	new[63]|new|new[66]	_	_
9-13	1254-1262	coupling	abstract[63]|abstract[66]	new[63]|new[66]	_	_
9-14	1263-1265	of	abstract[63]|abstract[66]	new[63]|new[66]	_	_
9-15	1266-1282	2-aminopyridines	abstract[63]|abstract[66]|substance	new[63]|new[66]|new	_	_
9-16	1283-1286	and	abstract[63]|abstract[66]	new[63]|new[66]	_	_
9-17	1287-1295	terminal	abstract[63]|abstract[66]|substance[68]	new[63]|new[66]|giv[68]	_	_
9-18	1296-1303	alkynes	abstract[63]|abstract[66]|substance[68]	new[63]|new[66]|giv[68]	_	_
9-19	1304-1308	with	abstract[63]|abstract[66]|substance[68]	new[63]|new[66]|giv[68]	_	_
9-20	1309-1316	visible	abstract[63]|abstract[66]|substance[68]|abstract[70]	new[63]|new[66]|giv[68]|new[70]	_	_
9-21	1317-1322	light	abstract[63]|abstract[66]|substance[68]|abstract|abstract[70]	new[63]|new[66]|giv[68]|new|new[70]	_	_
9-22	1323-1332	mediation	abstract[63]|abstract[66]|substance[68]|abstract[70]	new[63]|new[66]|giv[68]|new[70]	_	_
9-23	1333-1334	,	_	_	_	_
9-24	1335-1338	and	_	_	_	_
9-25	1339-1342	the	event[72]	giv[72]	coref	13-9[103_72]
9-26	1343-1349	direct	event[72]	giv[72]	_	_
9-27	1350-1359	oxidative	event[72]	giv[72]	_	_
9-28	1360-1369	amidation	substance|event[72]	giv|giv[72]	_	_
9-29	1370-1378	reaction	event[72]	giv[72]	_	_
9-30	1379-1381	of	event[72]	giv[72]	_	_
9-31	1382-1391	aldehydes	event[72]|substance[73]	giv[72]|giv[73]	_	_
9-32	1392-1396	with	event[72]|substance[73]	giv[72]|giv[73]	_	_
9-33	1397-1403	amines	event[72]|substance[73]|substance	giv[72]|giv[73]|giv	_	_
9-34	1404-1405	.	_	_	_	_

#Text=Since N-heterocyclic amides are increasingly being used in medicine , the discovery of a more effective approach to synthesize pyridyl benzamides is of great importance in the medical industry and has thus been attempted via numerous routes .
10-1	1406-1411	Since	_	_	_	_
10-2	1412-1426	N-heterocyclic	person|substance[76]	new|giv[76]	_	_
10-3	1427-1433	amides	substance[76]	giv[76]	_	_
10-4	1434-1437	are	_	_	_	_
10-5	1438-1450	increasingly	_	_	_	_
10-6	1451-1456	being	_	_	_	_
10-7	1457-1461	used	_	_	_	_
10-8	1462-1464	in	_	_	_	_
10-9	1465-1473	medicine	abstract	new	_	_
10-10	1474-1475	,	_	_	_	_
10-11	1476-1479	the	abstract[78]	new[78]	_	_
10-12	1480-1489	discovery	abstract[78]	new[78]	_	_
10-13	1490-1492	of	abstract[78]	new[78]	_	_
10-14	1493-1494	a	abstract[78]|abstract[79]	new[78]|new[79]	_	_
10-15	1495-1499	more	abstract[78]|abstract[79]	new[78]|new[79]	_	_
10-16	1500-1509	effective	abstract[78]|abstract[79]	new[78]|new[79]	_	_
10-17	1510-1518	approach	abstract[78]|abstract[79]	new[78]|new[79]	_	_
10-18	1519-1521	to	_	_	_	_
10-19	1522-1532	synthesize	_	_	_	_
10-20	1533-1540	pyridyl	abstract|substance[81]	giv|giv[81]	_	_
10-21	1541-1551	benzamides	substance[81]	giv[81]	_	_
10-22	1552-1554	is	_	_	_	_
10-23	1555-1557	of	_	_	_	_
10-24	1558-1563	great	abstract[82]	new[82]	_	_
10-25	1564-1574	importance	abstract[82]	new[82]	_	_
10-26	1575-1577	in	abstract[82]	new[82]	_	_
10-27	1578-1581	the	abstract[82]|abstract[83]	new[82]|new[83]	_	_
10-28	1582-1589	medical	abstract[82]|abstract[83]	new[82]|new[83]	_	_
10-29	1590-1598	industry	abstract[82]|abstract[83]	new[82]|new[83]	_	_
10-30	1599-1602	and	_	_	_	_
10-31	1603-1606	has	_	_	_	_
10-32	1607-1611	thus	_	_	_	_
10-33	1612-1616	been	_	_	_	_
10-34	1617-1626	attempted	_	_	_	_
10-35	1627-1630	via	_	_	_	_
10-36	1631-1639	numerous	abstract[84]	new[84]	_	_
10-37	1640-1646	routes	abstract[84]	new[84]	_	_
10-38	1647-1648	.	_	_	_	_

#Text=Xiao-Lan Xu et al. synthesized N-pyridinyl benzamide from benzoylformic acid and aniline using a transition metal catalyst , AgOTf .
11-1	1649-1657	Xiao-Lan	person[85]	new[85]	_	_
11-2	1658-1660	Xu	person[85]	new[85]	_	_
11-3	1661-1663	et	person[85]	new[85]	_	_
11-4	1664-1667	al.	person[85]	new[85]	_	_
11-5	1668-1679	synthesized	_	_	_	_
11-6	1680-1691	N-pyridinyl	abstract	new	coref	12-9
11-7	1692-1701	benzamide	_	_	_	_
11-8	1702-1706	from	_	_	_	_
11-9	1707-1720	benzoylformic	substance[87]	new[87]	coref	12-14[97_87]
11-10	1721-1725	acid	substance[87]	new[87]	_	_
11-11	1726-1729	and	_	_	_	_
11-12	1730-1737	aniline	substance	new	_	_
11-13	1738-1743	using	_	_	_	_
11-14	1744-1745	a	object[90]	new[90]	appos	11-19[0_90]
11-15	1746-1756	transition	object[90]	new[90]	_	_
11-16	1757-1762	metal	substance|object[90]	new|new[90]	coref	14-1
11-17	1763-1771	catalyst	object[90]	new[90]	_	_
11-18	1772-1773	,	_	_	_	_
11-19	1774-1779	AgOTf	object	giv	coref	12-20[101_0]
11-20	1780-1781	.	_	_	_	_

#Text=Additionally , Leiling Deng et al. also created N-pyridinyl benzamide from 2-aminopyridine and phenylacetic acid in the presence of a Cu salt catalyst .
12-1	1782-1794	Additionally	_	_	_	_
12-2	1795-1796	,	_	_	_	_
12-3	1797-1804	Leiling	person[92]	new[92]	_	_
12-4	1805-1809	Deng	person[92]	new[92]	_	_
12-5	1810-1812	et	_	_	_	_
12-6	1813-1816	al.	_	_	_	_
12-7	1817-1821	also	_	_	_	_
12-8	1822-1829	created	_	_	_	_
12-9	1830-1841	N-pyridinyl	abstract|substance[94]	giv|new[94]	coref|coref|coref|coref	13-13|13-13[105_94]|13-13|13-13[105_94]
12-10	1842-1851	benzamide	substance[94]	new[94]	_	_
12-11	1852-1856	from	_	_	_	_
12-12	1857-1872	2-aminopyridine	substance|substance[96]	new|new[96]	coref|coref|coref|coref	13-16|13-16[107_96]|13-16|13-16[107_96]
12-13	1873-1876	and	substance[96]	new[96]	_	_
12-14	1877-1889	phenylacetic	substance[96]|substance[97]	new[96]|giv[97]	_	_
12-15	1890-1894	acid	substance[96]|substance[97]	new[96]|giv[97]	_	_
12-16	1895-1897	in	_	_	_	_
12-17	1898-1901	the	abstract[98]	new[98]	_	_
12-18	1902-1910	presence	abstract[98]	new[98]	_	_
12-19	1911-1913	of	abstract[98]	new[98]	_	_
12-20	1914-1915	a	abstract[98]|object[101]	new[98]|giv[101]	coref	13-22[110_101]
12-21	1916-1918	Cu	abstract[98]|person|object[101]	new[98]|new|giv[101]	_	_
12-22	1919-1923	salt	abstract[98]|substance|object[101]	new[98]|new|giv[101]	_	_
12-23	1924-1932	catalyst	abstract[98]|object[101]	new[98]|giv[101]	_	_
12-24	1933-1934	.	_	_	_	_

#Text=Very recently , Zhengwang Chen et al. performed a reaction to synthesize N-pyridinyl benzamide from 2-aminopyridine and trans -β-nitrostyrene by utilizing Ce(NO3)3·6H2O catalyst in the absence of any oxidant or additive .
13-1	1935-1939	Very	_	_	_	_
13-2	1940-1948	recently	_	_	_	_
13-3	1949-1950	,	_	_	_	_
13-4	1951-1960	Zhengwang	person[102]	new[102]	_	_
13-5	1961-1965	Chen	person[102]	new[102]	_	_
13-6	1966-1968	et	_	_	_	_
13-7	1969-1972	al.	_	_	_	_
13-8	1973-1982	performed	_	_	_	_
13-9	1983-1984	a	event[103]	giv[103]	coref	23-25[203_103]
13-10	1985-1993	reaction	event[103]	giv[103]	_	_
13-11	1994-1996	to	_	_	_	_
13-12	1997-2007	synthesize	_	_	_	_
13-13	2008-2019	N-pyridinyl	abstract|substance[105]	giv|giv[105]	coref|coref|coref|coref	27-7|27-7[228_105]|27-7|27-7[228_105]
13-14	2020-2029	benzamide	substance[105]	giv[105]	_	_
13-15	2030-2034	from	_	_	_	_
13-16	2035-2050	2-aminopyridine	substance|substance[107]	giv|giv[107]	coref|coref	27-17|27-17
13-17	2051-2054	and	substance[107]	giv[107]	_	_
13-18	2055-2060	trans	substance[107]|substance[108]	giv[107]|new[108]	coref	27-14[231_108]
13-19	2061-2076	-β-nitrostyrene	substance[107]|substance[108]	giv[107]|new[108]	_	_
13-20	2077-2079	by	_	_	_	_
13-21	2080-2089	utilizing	_	_	_	_
13-22	2090-2103	Ce(NO3)3·6H2O	abstract|object[110]	new|giv[110]	coref|coref	28-1[235_110]|28-1[235_110]
13-23	2104-2112	catalyst	object[110]	giv[110]	_	_
13-24	2113-2115	in	_	_	_	_
13-25	2116-2119	the	abstract[111]	new[111]	_	_
13-26	2120-2127	absence	abstract[111]	new[111]	_	_
13-27	2128-2130	of	abstract[111]	new[111]	_	_
13-28	2131-2134	any	abstract[111]|person[112]	new[111]|new[112]	_	_
13-29	2135-2142	oxidant	abstract[111]|person[112]	new[111]|new[112]	_	_
13-30	2143-2145	or	abstract[111]	new[111]	_	_
13-31	2146-2154	additive	abstract[111]|substance	new[111]|new	_	_
13-32	2155-2156	.	_	_	_	_

#Text=Metal – organic frameworks ( MOFs ) , a class of porous materials with excellent potential , have been increasingly used in gas storage and separation because of their high capacity and selectivity properties .
14-1	2157-2162	Metal	person	giv	coref	15-20
14-2	2163-2164	–	_	_	_	_
14-3	2165-2172	organic	object[115]	new[115]	appos	14-6[0_115]
14-4	2173-2183	frameworks	object[115]	new[115]	_	_
14-5	2184-2185	(	_	_	_	_
14-6	2186-2190	MOFs	object	giv	ana	14-29
14-7	2191-2192	)	_	_	_	_
14-8	2193-2194	,	_	_	_	_
14-9	2195-2196	a	abstract[117]	new[117]	_	_
14-10	2197-2202	class	abstract[117]	new[117]	_	_
14-11	2203-2205	of	abstract[117]	new[117]	_	_
14-12	2206-2212	porous	abstract[117]|substance[118]	new[117]|new[118]	_	_
14-13	2213-2222	materials	abstract[117]|substance[118]	new[117]|new[118]	_	_
14-14	2223-2227	with	abstract[117]|substance[118]	new[117]|new[118]	_	_
14-15	2228-2237	excellent	abstract[117]|substance[118]|abstract[119]	new[117]|new[118]|new[119]	_	_
14-16	2238-2247	potential	abstract[117]|substance[118]|abstract[119]	new[117]|new[118]|new[119]	_	_
14-17	2248-2249	,	_	_	_	_
14-18	2250-2254	have	_	_	_	_
14-19	2255-2259	been	_	_	_	_
14-20	2260-2272	increasingly	_	_	_	_
14-21	2273-2277	used	_	_	_	_
14-22	2278-2280	in	_	_	_	_
14-23	2281-2284	gas	substance|abstract[121]	new|new[121]	_	_
14-24	2285-2292	storage	abstract[121]	new[121]	_	_
14-25	2293-2296	and	_	_	_	_
14-26	2297-2307	separation	abstract[122]	new[122]	_	_
14-27	2308-2315	because	abstract[122]	new[122]	_	_
14-28	2316-2318	of	abstract[122]	new[122]	_	_
14-29	2319-2324	their	abstract[122]|object|abstract[124]	new[122]|giv|new[124]	coref|coref	17-6|17-6
14-30	2325-2329	high	abstract[122]|abstract[124]	new[122]|new[124]	_	_
14-31	2330-2338	capacity	abstract[122]|abstract[124]	new[122]|new[124]	_	_
14-32	2339-2342	and	abstract[122]	new[122]	_	_
14-33	2343-2354	selectivity	abstract[122]|abstract|abstract[126]	new[122]|new|new[126]	coref|coref	19-13|19-13
14-34	2355-2365	properties	abstract[122]|abstract[126]	new[122]|new[126]	_	_
14-35	2366-2367	.	_	_	_	_

#Text=MOF crystals are built through the formation of secondary building units ( SBUs ) consisting of organic linkers and metal ions/clusters .
15-1	2368-2371	MOF	abstract|object[128]	new|new[128]	coref|coref	16-2|16-2
15-2	2372-2380	crystals	object[128]	new[128]	_	_
15-3	2381-2384	are	_	_	_	_
15-4	2385-2390	built	_	_	_	_
15-5	2391-2398	through	_	_	_	_
15-6	2399-2402	the	abstract[129]	new[129]	_	_
15-7	2403-2412	formation	abstract[129]	new[129]	_	_
15-8	2413-2415	of	abstract[129]	new[129]	_	_
15-9	2416-2425	secondary	abstract[129]|abstract[130]	new[129]|new[130]	appos	15-13[0_130]
15-10	2426-2434	building	abstract[129]|abstract[130]	new[129]|new[130]	_	_
15-11	2435-2440	units	abstract[129]|abstract[130]	new[129]|new[130]	_	_
15-12	2441-2442	(	_	_	_	_
15-13	2443-2447	SBUs	abstract	giv	_	_
15-14	2448-2449	)	_	_	_	_
15-15	2450-2460	consisting	_	_	_	_
15-16	2461-2463	of	_	_	_	_
15-17	2464-2471	organic	object[132]	new[132]	_	_
15-18	2472-2479	linkers	object[132]	new[132]	_	_
15-19	2480-2483	and	_	_	_	_
15-20	2484-2489	metal	substance|substance[134]	giv|new[134]	coref|coref|coref|coref	16-29|18-6[155_134]|16-29|18-6[155_134]
15-21	2490-2503	ions/clusters	substance[134]	new[134]	_	_
15-22	2504-2505	.	_	_	_	_

#Text=Numerous MOF structures have been designed to obtain different features such as enlarged surface areas , enhanced catalytic activity and electrical conductivity , better interaction at the open metal sites , and improved adsorption .
16-1	2506-2514	Numerous	abstract[136]	giv[136]	_	_
16-2	2515-2518	MOF	abstract|abstract[136]	giv|giv[136]	coref	19-7
16-3	2519-2529	structures	abstract[136]	giv[136]	_	_
16-4	2530-2534	have	_	_	_	_
16-5	2535-2539	been	_	_	_	_
16-6	2540-2548	designed	_	_	_	_
16-7	2549-2551	to	_	_	_	_
16-8	2552-2558	obtain	_	_	_	_
16-9	2559-2568	different	abstract[137]	new[137]	_	_
16-10	2569-2577	features	abstract[137]	new[137]	_	_
16-11	2578-2582	such	abstract[137]	new[137]	_	_
16-12	2583-2585	as	abstract[137]	new[137]	_	_
16-13	2586-2594	enlarged	abstract[137]|abstract[139]	new[137]|new[139]	_	_
16-14	2595-2602	surface	abstract[137]|place|abstract[139]	new[137]|new|new[139]	coref	22-13
16-15	2603-2608	areas	abstract[137]|abstract[139]	new[137]|new[139]	_	_
16-16	2609-2610	,	abstract[137]	new[137]	_	_
16-17	2611-2619	enhanced	abstract[137]|abstract[140]|abstract[141]	new[137]|new[140]|new[141]	coref|coref|coref|coref	19-10[165_140]|19-10[166_141]|19-10[165_140]|19-10[166_141]
16-18	2620-2629	catalytic	abstract[137]|abstract[140]|abstract[141]	new[137]|new[140]|new[141]	_	_
16-19	2630-2638	activity	abstract[137]|abstract[140]|abstract[141]	new[137]|new[140]|new[141]	_	_
16-20	2639-2642	and	abstract[137]|abstract[141]	new[137]|new[141]	_	_
16-21	2643-2653	electrical	abstract[137]|abstract[141]|abstract[142]	new[137]|new[141]|new[142]	_	_
16-22	2654-2666	conductivity	abstract[137]|abstract[141]|abstract[142]	new[137]|new[141]|new[142]	_	_
16-23	2667-2668	,	abstract[137]	new[137]	_	_
16-24	2669-2675	better	abstract[137]|abstract[143]	new[137]|new[143]	_	_
16-25	2676-2687	interaction	abstract[137]|abstract[143]	new[137]|new[143]	_	_
16-26	2688-2690	at	abstract[137]|abstract[143]	new[137]|new[143]	_	_
16-27	2691-2694	the	abstract[137]|abstract[143]|place[145]	new[137]|new[143]|new[145]	_	_
16-28	2695-2699	open	abstract[137]|abstract[143]|place[145]	new[137]|new[143]|new[145]	_	_
16-29	2700-2705	metal	abstract[137]|abstract[143]|substance|place[145]	new[137]|new[143]|giv|new[145]	coref	18-3
16-30	2706-2711	sites	abstract[137]|abstract[143]|place[145]	new[137]|new[143]|new[145]	_	_
16-31	2712-2713	,	abstract[137]|abstract[143]	new[137]|new[143]	_	_
16-32	2714-2717	and	abstract[137]|abstract[143]	new[137]|new[143]	_	_
16-33	2718-2726	improved	abstract[137]|abstract[143]|abstract[146]	new[137]|new[143]|new[146]	_	_
16-34	2727-2737	adsorption	abstract[137]|abstract[143]|abstract[146]	new[137]|new[143]|new[146]	_	_
16-35	2738-2739	.	_	_	_	_

#Text=Notably , the application of MOFs as effective catalysts for organic reactions has received much attention .
17-1	2740-2747	Notably	_	_	_	_
17-2	2748-2749	,	_	_	_	_
17-3	2750-2753	the	event[147]	new[147]	_	_
17-4	2754-2765	application	event[147]	new[147]	_	_
17-5	2766-2768	of	event[147]	new[147]	_	_
17-6	2769-2773	MOFs	event[147]|object	new[147]|giv	coref	18-1[151_0]
17-7	2774-2776	as	event[147]	new[147]	_	_
17-8	2777-2786	effective	event[147]	new[147]	_	_
17-9	2787-2796	catalysts	event[147]	new[147]	_	_
17-10	2797-2800	for	event[147]	new[147]	_	_
17-11	2801-2808	organic	event[147]|event[149]	new[147]|new[149]	coref	18-17[156_149]
17-12	2809-2818	reactions	event[147]|event[149]	new[147]|new[149]	_	_
17-13	2819-2822	has	_	_	_	_
17-14	2823-2831	received	_	_	_	_
17-15	2832-2836	much	abstract[150]	new[150]	_	_
17-16	2837-2846	attention	abstract[150]	new[150]	_	_
17-17	2847-2848	.	_	_	_	_

#Text=MOFs with metal nodes ( metal ions/clusters ) can act as the active catalytic sites for many organic reactions such as oxidation reactions , C – C coupling reactions , and hydrogenation reactions .
18-1	2849-2853	MOFs	object[151]	giv[151]	coref	21-6[0_151]
18-2	2854-2858	with	object[151]	giv[151]	_	_
18-3	2859-2864	metal	object[151]|substance|place[153]	giv[151]|giv|new[153]	coref|coref	18-6|18-6
18-4	2865-2870	nodes	object[151]|place[153]	giv[151]|new[153]	_	_
18-5	2871-2872	(	_	_	_	_
18-6	2873-2878	metal	substance|substance[155]	giv|giv[155]	coref|coref	20-3[169_0]|20-3[169_0]
18-7	2879-2892	ions/clusters	substance[155]	giv[155]	_	_
18-8	2893-2894	)	_	_	_	_
18-9	2895-2898	can	_	_	_	_
18-10	2899-2902	act	_	_	_	_
18-11	2903-2905	as	_	_	_	_
18-12	2906-2909	the	_	_	_	_
18-13	2910-2916	active	_	_	_	_
18-14	2917-2926	catalytic	_	_	_	_
18-15	2927-2932	sites	_	_	_	_
18-16	2933-2936	for	_	_	_	_
18-17	2937-2941	many	event[156]	giv[156]	coref	25-26[214_156]
18-18	2942-2949	organic	event[156]	giv[156]	_	_
18-19	2950-2959	reactions	event[156]	giv[156]	_	_
18-20	2960-2964	such	event[156]	giv[156]	_	_
18-21	2965-2967	as	event[156]	giv[156]	_	_
18-22	2968-2977	oxidation	event[156]|abstract	giv[156]|giv	_	_
18-23	2978-2987	reactions	event[156]	giv[156]	_	_
18-24	2988-2989	,	event[156]	giv[156]	_	_
18-25	2990-2991	C	event[156]|person	giv[156]|new	coref	18-27
18-26	2992-2993	–	event[156]	giv[156]	_	_
18-27	2994-2995	C	event[156]|person	giv[156]|giv	_	_
18-28	2996-3004	coupling	event[156]|abstract	giv[156]|giv	_	_
18-29	3005-3014	reactions	event[156]	giv[156]	_	_
18-30	3015-3016	,	event[156]	giv[156]	_	_
18-31	3017-3020	and	event[156]	giv[156]	_	_
18-32	3021-3034	hydrogenation	event[156]|event	giv[156]|new	_	_
18-33	3035-3044	reactions	event[156]	giv[156]	_	_
18-34	3045-3046	.	_	_	_	_

#Text=However , the fabrication of a MOF structure with high activity and selectivity still requires further investigation .
19-1	3047-3054	However	_	_	_	_
19-2	3055-3056	,	_	_	_	_
19-3	3057-3060	the	abstract[162]	new[162]	_	_
19-4	3061-3072	fabrication	abstract[162]	new[162]	_	_
19-5	3073-3075	of	abstract[162]	new[162]	_	_
19-6	3076-3077	a	abstract[162]|abstract[164]	new[162]|new[164]	coref	26-25[224_164]
19-7	3078-3081	MOF	abstract[162]|place|abstract[164]	new[162]|giv|new[164]	_	_
19-8	3082-3091	structure	abstract[162]|abstract[164]	new[162]|new[164]	_	_
19-9	3092-3096	with	abstract[162]|abstract[164]	new[162]|new[164]	_	_
19-10	3097-3101	high	abstract[162]|abstract[164]|abstract[165]|abstract[166]	new[162]|new[164]|giv[165]|giv[166]	coref|coref	22-10[0_165]|22-10[0_165]
19-11	3102-3110	activity	abstract[162]|abstract[164]|abstract[165]|abstract[166]	new[162]|new[164]|giv[165]|giv[166]	_	_
19-12	3111-3114	and	abstract[162]|abstract[164]|abstract[166]	new[162]|new[164]|giv[166]	_	_
19-13	3115-3126	selectivity	abstract[162]|abstract[164]|abstract[166]|abstract	new[162]|new[164]|giv[166]|giv	_	_
19-14	3127-3132	still	_	_	_	_
19-15	3133-3141	requires	_	_	_	_
19-16	3142-3149	further	abstract[168]	new[168]	_	_
19-17	3150-3163	investigation	abstract[168]	new[168]	_	_
19-18	3164-3165	.	_	_	_	_

#Text=Recently , a new bimetallic metal – organic framework ( BMOF ) with a synergistic effect between different metal ions was developed .
20-1	3166-3174	Recently	_	_	_	_
20-2	3175-3176	,	_	_	_	_
20-3	3177-3178	a	substance[169]	giv[169]	coref	20-19[0_169]
20-4	3179-3182	new	substance[169]	giv[169]	_	_
20-5	3183-3193	bimetallic	substance[169]	giv[169]	_	_
20-6	3194-3199	metal	substance[169]	giv[169]	_	_
20-7	3200-3201	–	_	_	_	_
20-8	3202-3209	organic	object[170]	new[170]	appos	20-11[0_170]
20-9	3210-3219	framework	object[170]	new[170]	_	_
20-10	3220-3221	(	_	_	_	_
20-11	3222-3226	BMOF	object	giv	coref	21-22[182_0]
20-12	3227-3228	)	_	_	_	_
20-13	3229-3233	with	_	_	_	_
20-14	3234-3235	a	abstract[172]	new[172]	coref	25-10[209_172]
20-15	3236-3247	synergistic	abstract[172]	new[172]	_	_
20-16	3248-3254	effect	abstract[172]	new[172]	_	_
20-17	3255-3262	between	abstract[172]	new[172]	_	_
20-18	3263-3272	different	abstract[172]|substance[174]	new[172]|new[174]	coref	21-33[186_174]
20-19	3273-3278	metal	abstract[172]|substance|substance[174]	new[172]|giv|new[174]	coref	21-10
20-20	3279-3283	ions	abstract[172]|substance[174]	new[172]|new[174]	_	_
20-21	3284-3287	was	_	_	_	_
20-22	3288-3297	developed	_	_	_	_
20-23	3298-3299	.	_	_	_	_

#Text=Different from the synthesis of MOFs where only one metal ion is combined with organic ligands , the synthesis process of a BMOF produces the pure phase of the BMOF by combining two different metal ions with organic ligands .
21-1	3300-3309	Different	_	_	_	_
21-2	3310-3314	from	_	_	_	_
21-3	3315-3318	the	abstract[175]	new[175]	coref	21-19[0_175]
21-4	3319-3328	synthesis	abstract[175]	new[175]	_	_
21-5	3329-3331	of	abstract[175]	new[175]	_	_
21-6	3332-3336	MOFs	abstract[175]|object	new[175]|giv	coref	23-34[204_0]
21-7	3337-3342	where	_	_	_	_
21-8	3343-3347	only	substance[178]	new[178]	_	_
21-9	3348-3351	one	substance[178]	new[178]	_	_
21-10	3352-3357	metal	substance|substance[178]	giv|new[178]	coref	21-35
21-11	3358-3361	ion	substance[178]	new[178]	_	_
21-12	3362-3364	is	_	_	_	_
21-13	3365-3373	combined	_	_	_	_
21-14	3374-3378	with	_	_	_	_
21-15	3379-3386	organic	substance[179]	new[179]	coref	21-38[187_179]
21-16	3387-3394	ligands	substance[179]	new[179]	_	_
21-17	3395-3396	,	_	_	_	_
21-18	3397-3400	the	event[181]	new[181]	_	_
21-19	3401-3410	synthesis	abstract|event[181]	giv|new[181]	coref	25-27
21-20	3411-3418	process	event[181]	new[181]	_	_
21-21	3419-3421	of	event[181]	new[181]	_	_
21-22	3422-3423	a	event[181]|object[182]	new[181]|giv[182]	coref	21-29[184_182]
21-23	3424-3428	BMOF	event[181]|object[182]	new[181]|giv[182]	_	_
21-24	3429-3437	produces	_	_	_	_
21-25	3438-3441	the	abstract[183]	new[183]	_	_
21-26	3442-3446	pure	abstract[183]	new[183]	_	_
21-27	3447-3452	phase	abstract[183]	new[183]	_	_
21-28	3453-3455	of	abstract[183]	new[183]	_	_
21-29	3456-3459	the	abstract[183]|object[184]	new[183]|giv[184]	coref	25-13[210_184]
21-30	3460-3464	BMOF	abstract[183]|object[184]	new[183]|giv[184]	_	_
21-31	3465-3467	by	_	_	_	_
21-32	3468-3477	combining	_	_	_	_
21-33	3478-3481	two	substance[186]	giv[186]	coref	23-15[199_186]
21-34	3482-3491	different	substance[186]	giv[186]	_	_
21-35	3492-3497	metal	substance|substance[186]	giv|giv[186]	_	_
21-36	3498-3502	ions	substance[186]	giv[186]	_	_
21-37	3503-3507	with	substance[186]	giv[186]	_	_
21-38	3508-3515	organic	substance[186]|object[187]	giv[186]|giv[187]	_	_
21-39	3516-3523	ligands	substance[186]|object[187]	giv[186]|giv[187]	_	_
21-40	3524-3525	.	_	_	_	_

#Text=The BMOFs are expected to have improved stability , activity , and surface area and could be applicable in catalysis .
22-1	3526-3529	The	object[188]	new[188]	coref	24-8[0_188]
22-2	3530-3535	BMOFs	object[188]	new[188]	_	_
22-3	3536-3539	are	_	_	_	_
22-4	3540-3548	expected	_	_	_	_
22-5	3549-3551	to	_	_	_	_
22-6	3552-3556	have	_	_	_	_
22-7	3557-3565	improved	abstract[189]	new[189]	_	_
22-8	3566-3575	stability	abstract[189]	new[189]	_	_
22-9	3576-3577	,	_	_	_	_
22-10	3578-3586	activity	abstract	giv	coref	23-21[200_0]
22-11	3587-3588	,	_	_	_	_
22-12	3589-3592	and	_	_	_	_
22-13	3593-3600	surface	place|abstract[192]	giv|new[192]	_	_
22-14	3601-3605	area	abstract[192]	new[192]	_	_
22-15	3606-3609	and	_	_	_	_
22-16	3610-3615	could	_	_	_	_
22-17	3616-3618	be	_	_	_	_
22-18	3619-3629	applicable	_	_	_	_
22-19	3630-3632	in	_	_	_	_
22-20	3633-3642	catalysis	abstract	new	coref	30-18[252_0]
22-21	3643-3644	.	_	_	_	_

#Text=For example , an Fe/Co mixed Hofmann MOF with coupling effects between Co2+ and Fe2+ ions was found to exhibit enhanced catalytic activity for an oxygen evolution reaction compared to that exhibited by the original single-metal MOFs .
23-1	3645-3648	For	_	_	_	_
23-2	3649-3656	example	_	_	_	_
23-3	3657-3658	,	_	_	_	_
23-4	3659-3661	an	substance[194]	new[194]	_	_
23-5	3662-3667	Fe/Co	substance[194]	new[194]	_	_
23-6	3668-3673	mixed	substance[194]	new[194]	_	_
23-7	3674-3681	Hofmann	substance[194]|person	new[194]|new	_	_
23-8	3682-3685	MOF	substance[194]	new[194]	_	_
23-9	3686-3690	with	_	_	_	_
23-10	3691-3699	coupling	_	_	_	_
23-11	3700-3707	effects	abstract[196]	new[196]	_	_
23-12	3708-3715	between	abstract[196]	new[196]	_	_
23-13	3716-3720	Co2+	abstract[196]|substance	new[196]|new	_	_
23-14	3721-3724	and	abstract[196]	new[196]	_	_
23-15	3725-3729	Fe2+	abstract[196]|abstract|substance[199]	new[196]|new|giv[199]	_	_
23-16	3730-3734	ions	abstract[196]|substance[199]	new[196]|giv[199]	_	_
23-17	3735-3738	was	_	_	_	_
23-18	3739-3744	found	_	_	_	_
23-19	3745-3747	to	_	_	_	_
23-20	3748-3755	exhibit	_	_	_	_
23-21	3756-3764	enhanced	abstract[200]	giv[200]	_	_
23-22	3765-3774	catalytic	abstract[200]	giv[200]	_	_
23-23	3775-3783	activity	abstract[200]	giv[200]	_	_
23-24	3784-3787	for	abstract[200]	giv[200]	_	_
23-25	3788-3790	an	abstract[200]|event[203]	giv[200]|giv[203]	coref	28-13[239_203]
23-26	3791-3797	oxygen	abstract[200]|substance|event[203]	giv[200]|new|giv[203]	_	_
23-27	3798-3807	evolution	abstract[200]|abstract|event[203]	giv[200]|new|giv[203]	_	_
23-28	3808-3816	reaction	abstract[200]|event[203]	giv[200]|giv[203]	_	_
23-29	3817-3825	compared	_	_	_	_
23-30	3826-3828	to	_	_	_	_
23-31	3829-3833	that	_	_	_	_
23-32	3834-3843	exhibited	_	_	_	_
23-33	3844-3846	by	_	_	_	_
23-34	3847-3850	the	object[204]	giv[204]	_	_
23-35	3851-3859	original	object[204]	giv[204]	_	_
23-36	3860-3872	single-metal	object[204]	giv[204]	_	_
23-37	3873-3877	MOFs	object[204]	giv[204]	_	_
23-38	3878-3879	.	_	_	_	_

#Text=Despite this , the catalysis applications of BMOFs have not been investigated so far .
24-1	3880-3887	Despite	_	_	_	_
24-2	3888-3892	this	_	_	_	_
24-3	3893-3894	,	_	_	_	_
24-4	3895-3898	the	abstract[205]	new[205]	_	_
24-5	3899-3908	catalysis	abstract[205]	new[205]	_	_
24-6	3909-3921	applications	abstract[205]	new[205]	_	_
24-7	3922-3924	of	abstract[205]	new[205]	_	_
24-8	3925-3930	BMOFs	abstract[205]|object	new[205]|giv	_	_
24-9	3931-3935	have	_	_	_	_
24-10	3936-3939	not	_	_	_	_
24-11	3940-3944	been	_	_	_	_
24-12	3945-3957	investigated	_	_	_	_
24-13	3958-3960	so	_	_	_	_
24-14	3961-3964	far	_	_	_	_
24-15	3965-3966	.	_	_	_	_

#Text=The main aim of this study was to appraise the effect of a new BMOF ( Fe2Ni-1,4-Benzenedicarboxylic , Fe2Ni-BDC ) as a heterogenous catalyst for organic synthesis reactions .
25-1	3967-3970	The	abstract[207]	new[207]	_	_
25-2	3971-3975	main	abstract[207]	new[207]	_	_
25-3	3976-3979	aim	abstract[207]	new[207]	_	_
25-4	3980-3982	of	abstract[207]	new[207]	_	_
25-5	3983-3987	this	abstract[207]|event[208]	new[207]|new[208]	_	_
25-6	3988-3993	study	abstract[207]|event[208]	new[207]|new[208]	_	_
25-7	3994-3997	was	_	_	_	_
25-8	3998-4000	to	_	_	_	_
25-9	4001-4009	appraise	_	_	_	_
25-10	4010-4013	the	abstract[209]	giv[209]	_	_
25-11	4014-4020	effect	abstract[209]	giv[209]	_	_
25-12	4021-4023	of	abstract[209]	giv[209]	_	_
25-13	4024-4025	a	abstract[209]|object[210]	giv[209]|giv[210]	_	_
25-14	4026-4029	new	abstract[209]|object[210]	giv[209]|giv[210]	_	_
25-15	4030-4034	BMOF	abstract[209]|object[210]	giv[209]|giv[210]	_	_
25-16	4035-4036	(	_	_	_	_
25-17	4037-4066	Fe2Ni-1,4-Benzenedicarboxylic	substance	new	_	_
25-18	4067-4068	,	_	_	_	_
25-19	4069-4078	Fe2Ni-BDC	substance	new	coref	26-1
25-20	4079-4080	)	_	_	_	_
25-21	4081-4083	as	_	_	_	_
25-22	4084-4085	a	_	_	_	_
25-23	4086-4098	heterogenous	_	_	_	_
25-24	4099-4107	catalyst	_	_	_	_
25-25	4108-4111	for	_	_	_	_
25-26	4112-4119	organic	event[214]	giv[214]	_	_
25-27	4120-4129	synthesis	abstract|event[214]	giv|giv[214]	_	_
25-28	4130-4139	reactions	event[214]	giv[214]	_	_
25-29	4140-4141	.	_	_	_	_

#Text=Fe2Ni-BDC was generated by bridging iron ( III ) cations and nickel ( II ) cations with 1,4-Benzenedicarboxylic anions ( BDC− ) to create a porous three-dimensional structure .
26-1	4142-4151	Fe2Ni-BDC	substance	giv	coref	27-19[233_0]
26-2	4152-4155	was	_	_	_	_
26-3	4156-4165	generated	_	_	_	_
26-4	4166-4168	by	_	_	_	_
26-5	4169-4177	bridging	_	_	_	_
26-6	4178-4182	iron	substance	new	_	_
26-7	4183-4184	(	_	_	_	_
26-8	4185-4188	III	person	new	_	_
26-9	4189-4190	)	_	_	_	_
26-10	4191-4198	cations	substance	new	_	_
26-11	4199-4202	and	_	_	_	_
26-12	4203-4209	nickel	quantity	new	_	_
26-13	4210-4211	(	_	_	_	_
26-14	4212-4214	II	person	new	_	_
26-15	4215-4216	)	_	_	_	_
26-16	4217-4224	cations	substance[221]	new[221]	_	_
26-17	4225-4229	with	substance[221]	new[221]	_	_
26-18	4230-4253	1,4-Benzenedicarboxylic	substance[221]|substance[222]	new[221]|new[222]	_	_
26-19	4254-4260	anions	substance[221]|substance[222]	new[221]|new[222]	_	_
26-20	4261-4262	(	_	_	_	_
26-21	4263-4267	BDC−	object	new	_	_
26-22	4268-4269	)	_	_	_	_
26-23	4270-4272	to	_	_	_	_
26-24	4273-4279	create	_	_	_	_
26-25	4280-4281	a	abstract[224]	giv[224]	_	_
26-26	4282-4288	porous	abstract[224]	giv[224]	_	_
26-27	4289-4306	three-dimensional	abstract[224]	giv[224]	_	_
26-28	4307-4316	structure	abstract[224]	giv[224]	_	_
26-29	4317-4318	.	_	_	_	_

#Text=We also investigated the synthesis of N-pyridinyl benzamide via the amidation process of trans -β-nitrostyrene and 2-aminopyridine using Fe2Ni-BDC as an effective heterogeneous catalyst , without using added reducing agents or oxidizing agents .
27-1	4319-4321	We	person	acc	ana	30-5
27-2	4322-4326	also	_	_	_	_
27-3	4327-4339	investigated	_	_	_	_
27-4	4340-4343	the	abstract[226]	new[226]	_	_
27-5	4344-4353	synthesis	abstract[226]	new[226]	_	_
27-6	4354-4356	of	abstract[226]	new[226]	_	_
27-7	4357-4368	N-pyridinyl	abstract[226]|abstract|substance[228]	new[226]|giv|giv[228]	coref|coref|coref|coref	28-10|28-10[238_228]|28-10|28-10[238_228]
27-8	4369-4378	benzamide	abstract[226]|substance[228]	new[226]|giv[228]	_	_
27-9	4379-4382	via	abstract[226]	new[226]	_	_
27-10	4383-4386	the	abstract[226]|abstract[229]	new[226]|new[229]	_	_
27-11	4387-4396	amidation	abstract[226]|abstract[229]	new[226]|new[229]	_	_
27-12	4397-4404	process	abstract[226]|abstract[229]	new[226]|new[229]	_	_
27-13	4405-4407	of	abstract[226]|abstract[229]	new[226]|new[229]	_	_
27-14	4408-4413	trans	abstract[226]|abstract[229]|person|abstract[231]	new[226]|new[229]|new|giv[231]	_	_
27-15	4414-4429	-β-nitrostyrene	abstract[226]|abstract[229]|abstract[231]	new[226]|new[229]|giv[231]	_	_
27-16	4430-4433	and	abstract[226]|abstract[229]	new[226]|new[229]	_	_
27-17	4434-4449	2-aminopyridine	abstract[226]|abstract[229]|substance	new[226]|new[229]|giv	_	_
27-18	4450-4455	using	_	_	_	_
27-19	4456-4465	Fe2Ni-BDC	substance[233]	giv[233]	coref	29-1[0_233]
27-20	4466-4468	as	substance[233]	giv[233]	_	_
27-21	4469-4471	an	substance[233]	giv[233]	_	_
27-22	4472-4481	effective	substance[233]	giv[233]	_	_
27-23	4482-4495	heterogeneous	substance[233]	giv[233]	_	_
27-24	4496-4504	catalyst	substance[233]	giv[233]	_	_
27-25	4505-4506	,	_	_	_	_
27-26	4507-4514	without	_	_	_	_
27-27	4515-4520	using	_	_	_	_
27-28	4521-4526	added	_	_	_	_
27-29	4527-4535	reducing	_	_	_	_
27-30	4536-4542	agents	person[234]	giv[234]	_	_
27-31	4543-4545	or	person[234]	giv[234]	_	_
27-32	4546-4555	oxidizing	person[234]	giv[234]	_	_
27-33	4556-4562	agents	person[234]	giv[234]	_	_
27-34	4563-4564	.	_	_	_	_

#Text=This catalyst might be reused for the creation of N-pyridinyl benzamide by the amidation reaction without significant depreciation in its efficiency .
28-1	4565-4569	This	object[235]	giv[235]	coref	29-13[245_235]
28-2	4570-4578	catalyst	object[235]	giv[235]	_	_
28-3	4579-4584	might	_	_	_	_
28-4	4585-4587	be	_	_	_	_
28-5	4588-4594	reused	_	_	_	_
28-6	4595-4598	for	_	_	_	_
28-7	4599-4602	the	event[236]	new[236]	_	_
28-8	4603-4611	creation	event[236]	new[236]	_	_
28-9	4612-4614	of	event[236]	new[236]	_	_
28-10	4615-4626	N-pyridinyl	event[236]|abstract|substance[238]	new[236]|giv|giv[238]	_	_
28-11	4627-4636	benzamide	event[236]|substance[238]	new[236]|giv[238]	_	_
28-12	4637-4639	by	_	_	_	_
28-13	4640-4643	the	event[239]	giv[239]	coref	29-18[246_239]
28-14	4644-4653	amidation	event[239]	giv[239]	_	_
28-15	4654-4662	reaction	event[239]	giv[239]	_	_
28-16	4663-4670	without	event[239]	giv[239]	_	_
28-17	4671-4682	significant	event[239]|abstract[240]	giv[239]|new[240]	_	_
28-18	4683-4695	depreciation	event[239]|abstract[240]	giv[239]|new[240]	_	_
28-19	4696-4698	in	event[239]|abstract[240]	giv[239]|new[240]	_	_
28-20	4699-4702	its	event[239]|abstract[240]|abstract[241]	giv[239]|new[240]|new[241]	_	_
28-21	4703-4713	efficiency	event[239]|abstract[240]|abstract[241]	giv[239]|new[240]|new[241]	_	_
28-22	4714-4715	.	_	_	_	_

#Text=Fe2Ni-BDC is also satisfactory from the view of green chemistry , as the solid catalyst used for the reaction can be easily recovered and reused .
29-1	4716-4725	Fe2Ni-BDC	substance	giv	_	_
29-2	4726-4728	is	_	_	_	_
29-3	4729-4733	also	_	_	_	_
29-4	4734-4746	satisfactory	_	_	_	_
29-5	4747-4751	from	_	_	_	_
29-6	4752-4755	the	abstract[243]	new[243]	_	_
29-7	4756-4760	view	abstract[243]	new[243]	_	_
29-8	4761-4763	of	abstract[243]	new[243]	_	_
29-9	4764-4769	green	abstract[243]|abstract[244]	new[243]|new[244]	_	_
29-10	4770-4779	chemistry	abstract[243]|abstract[244]	new[243]|new[244]	_	_
29-11	4780-4781	,	_	_	_	_
29-12	4782-4784	as	_	_	_	_
29-13	4785-4788	the	object[245]	giv[245]	_	_
29-14	4789-4794	solid	object[245]	giv[245]	_	_
29-15	4795-4803	catalyst	object[245]	giv[245]	_	_
29-16	4804-4808	used	_	_	_	_
29-17	4809-4812	for	_	_	_	_
29-18	4813-4816	the	event[246]	giv[246]	_	_
29-19	4817-4825	reaction	event[246]	giv[246]	_	_
29-20	4826-4829	can	_	_	_	_
29-21	4830-4832	be	_	_	_	_
29-22	4833-4839	easily	_	_	_	_
29-23	4840-4849	recovered	_	_	_	_
29-24	4850-4853	and	_	_	_	_
29-25	4854-4860	reused	_	_	_	_
29-26	4861-4862	.	_	_	_	_

#Text=To the best of our knowledge , C=C double bond cleavage has not previously been performed using heterogeneous catalysis .
30-1	4863-4865	To	_	_	_	_
30-2	4866-4869	the	_	_	_	_
30-3	4870-4874	best	_	_	_	_
30-4	4875-4877	of	_	_	_	_
30-5	4878-4881	our	person|abstract[248]	giv|new[248]	_	_
30-6	4882-4891	knowledge	abstract[248]	new[248]	_	_
30-7	4892-4893	,	_	_	_	_
30-8	4894-4897	C=C	abstract|abstract[251]	new|new[251]	_	_
30-9	4898-4904	double	abstract[251]	new[251]	_	_
30-10	4905-4909	bond	abstract|abstract[251]	new|new[251]	_	_
30-11	4910-4918	cleavage	abstract[251]	new[251]	_	_
30-12	4919-4922	has	_	_	_	_
30-13	4923-4926	not	_	_	_	_
30-14	4927-4937	previously	_	_	_	_
30-15	4938-4942	been	_	_	_	_
30-16	4943-4952	performed	_	_	_	_
30-17	4953-4958	using	_	_	_	_
30-18	4959-4972	heterogeneous	abstract[252]	giv[252]	_	_
30-19	4973-4982	catalysis	abstract[252]	giv[252]	_	_
30-20	4983-4984	.	_	_	_	_
